Clinical Trial: Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433413) titled 'Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder' on Feb. 08.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial.

The study plans to enroll 240 adult patients with Alcohol Use Disorder (AUD). After providing written informed consent and undergoing screening for eligibility criteria, eligible subjects will be randomized in a 2:1 ratio to receive treatment in either the experimental group (1.5 g Naltrexone Hydrochloride Implant plus non-specific supportive psychotherapy) or the control group (placebo implant plus non-spe...